Determinants of response to the glucagon-like peptide-1 receptor agonists in a type 2 diabetes population in the real-world

To identify clinical predictors associated with a response in terms of glycemic control and weight loss in patients with type 2 diabetes treated with glucagon-like peptide-1 receptor agonists (GLP-1RAs).

Bibliographische Detailangaben
Veröffentlicht in:A pilot randomized controlled trial examining the feasibility, acceptability, and efficacy of Adapted Motivational Interviewing for post-operative bariatric surgery patients. - 2016. - Amsterdam [u.a.]
1. Verfasser: Franch-Nadal, Josep (VerfasserIn)
Weitere Verfasser: Granado-Casas, Minerva (BerichterstatterIn), Mata-Cases, Manel (BerichterstatterIn), Ortega, Emilio (BerichterstatterIn), Vlacho, Bogdan (BerichterstatterIn), Mauricio, Didac (BerichterstatterIn)
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2022
Zugriff auf das übergeordnete Werk:A pilot randomized controlled trial examining the feasibility, acceptability, and efficacy of Adapted Motivational Interviewing for post-operative bariatric surgery patients
Schlagworte:eGFR FDA OR CI ITT SIDIAP EASD MPR RCTs GLP-1RAs mehr... ICS NIADs NICE DPP4i CKD-EPI HbA1c SGLT2i ADA BMI WHO
Umfang:8
Beschreibung
Zusammenfassung:To identify clinical predictors associated with a response in terms of glycemic control and weight loss in patients with type 2 diabetes treated with glucagon-like peptide-1 receptor agonists (GLP-1RAs).
Beschreibung:8
DOI:10.1016/j.pcd.2022.10.005